MSC−sEV Treatment Polarizes Pro−Fibrotic M2 Macrophages without Exacerbating Liver Fibrosis in NASH
Mesenchymal stem/stromal cell small extracellular vesicles (MSC−sEVs) have shown promise in treating a wide range of animal models of various human diseases, which has led to their consideration for clinical translation. However, the possibility of contraindication for MSC−sEV use is an important co...
Main Authors: | Lai, R.C (Author), Lam, K.P (Author), Lim, S.K (Author), Sim, W.K (Author), Zhang, B. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2023
|
Subjects: | |
Online Access: | View Fulltext in Publisher View in Scopus |
Similar Items
-
NANOmetric BIO-Banked MSC-Derived Exosome (NANOBIOME) as a Novel Approach to Regenerative Medicine
by: Bruna Codispoti, et al.
Published: (2018-10-01) -
Signaling of Tumor-Derived sEV Impacts Melanoma Progression
by: Aneta Zebrowska, et al.
Published: (2020-07-01) -
ESC‐sEVs Rejuvenate Senescent Hippocampal NSCs by Activating Lysosomes to Improve Cognitive Dysfunction in Vascular Dementia
by: Guowen Hu, et al.
Published: (2020-05-01) -
Implementation of highly sensitive small extracellular vesicle (sEV) quantification method in the identification of novel sEV production modulators and the evaluation of sEV pharmacokinetics
by: Yamamoto, Aki
Published: (2021) -
Clinical Applications of Mesenchymal Stem/Stromal Cell Derived Extracellular Vesicles: Therapeutic Potential of an Acellular Product
by: Margherita Massa, et al.
Published: (2020-11-01)